Skip to main content
MedPathMedPath Home
Clinical Trials/JPRN-jRCTb030210146
JPRN-jRCTb030210146
Recruiting
未知

Total Autologous Angiogenic Therapy with Cultured Bone Marrow Derived Mesenchymal Stromal Cells Grown in Platelet-Rich Plasma Against Peripheral Arterial Disease. - Advanced Medical Care - - TAAT Advance

Fukuda Shoji0 sites50 target enrollmentJune 11, 2021
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit

Overview

Phase
未知
Intervention
Not specified
Conditions
Not specified
Sponsor
Fukuda Shoji
Enrollment
50
Status
Recruiting
Last Updated
2 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
June 11, 2021
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Fukuda Shoji

Eligibility Criteria

Inclusion Criteria

  • •\# Patients with Severe PAD (Peripheral Arterial Disease)
  • •\# 20\<\= Age \<\=80
  • •\# informed consent

Exclusion Criteria

  • •\# A past 3 months or current history of alcoholism or drug dependence
  • •\# A past 5 years or current history of malignant disease
  • •\# Untreated diabetic retinopathy
  • •\# No informed consent

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Therapeutic Angiogenesis using Autologous Bone-Marrow Mononuclear Cells ImplantatioCLI(Critical limb ischemia) (ASO, Buerger disease, Collagen disease)
JPRN-UMIN000023282Kyoto Prefectural University School of Medicine120
Recruiting
Phase 1
ICS-001-1CLTI (ASO or Buerger's disease) with refractory ulcer refractory to existing therapy
JPRN-jRCT2052230115Kenichi Yamahara6
Completed
Phase 1
Vascular regeneration therapy using autologous peripheral blood mononuclear cells for refractory skin ulcer associated with connective tissue diseases and vasculitisPatients with refractory skin ulcers resistant to normal treatment, mainly caused by connective tissue diseases and vasculitis
JPRN-UMIN000024255Kumamoto University10
Not yet recruiting
Not Applicable
Therapeutic angiogenesis using autologous bone marrow mononuclear cells implantation for Buerger diseaseCLI(Critical limb ischemia) (Buerger disease)
JPRN-UMIN000027383Kyoto Prefectural University School of Medicine25
Recruiting
Not Applicable
A new treatment for skin ulcers associated with systemic sclerosis using the ability of own bone marrow cells to regenerate blood vesselsSystemic sclerosisSystemic sclerosis, Vasculopathy, Skin ulcer, Raynaud's phenomenon
JPRN-jRCTb032210204Yoshimi Ryusuke12